Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- New Study Results Reaffirms Diachrome® Significantly Improves Cardiovascular Disease Risk Factors In People With Type 2 Diabetes
Results of Clinical Trial Examining Effects of Diachrome on Atherogenic Index of Plasma Presented at 2nd International Symposium on Triglycerides and HDL
- Sabinsa Corporation's Selenium SeLECT Certified by NSF International
Sabinsa Corporation, announced that its Selenium SeLECT brand L-(+)-Selenomethionine ingredient has been certified by NSF International. NSF conducted rigorous toxicology reviews and purity testing to guarantee that Selenium SeLECT is free of contaminants.
- Sabinsa Corporation's Selenium SeLECT Certified by NSF International
Sabinsa Corporation, announced that its Selenium SeLECT brand L-(+)-Selenomethionine ingredient has been certified by NSF International. NSF conducted rigorous toxicology reviews and purity testing to guarantee that Selenium SeLECT is free of contaminants.
- Sabinsa Corporation's Selenium SeLECT Certified by NSF International
Sabinsa Corporation, announced that its Selenium SeLECT brand L-(+)-Selenomethionine ingredient has been certified by NSF International. NSF conducted rigorous toxicology reviews and purity testing to guarantee that Selenium SeLECT is free of contaminants.
- Sabinsa Corporation's Selenium SeLECT Certified by NSF International
Sabinsa Corporation, announced that its Selenium SeLECT brand L-(+)-Selenomethionine ingredient has been certified by NSF International. NSF conducted rigorous toxicology reviews and purity testing to guarantee that Selenium SeLECT is free of contaminants.
- BioLogic Health Solutions Receives Grant From Queensland Government to Conduct Further Research in U.S.
Australia-based BioLogic Health Solutions Pty Ltd., makers of UroLogic(TM), a branded dietary ingredient designed to address overactive bladder and incontinence associated with aging and childbirth, has received a large grant from the Queensland Minister for State Development and Innovation that will enable the company to further research the effectiveness of its signature ingredient, UroLogic, by undertaking more clinical trials and safety testing in the United States.
- BioLogic Health Solutions Receives Grant From Queensland Government to Conduct Further Research in U.S.
Australia-based BioLogic Health Solutions Pty Ltd., makers of UroLogic(TM), a branded dietary ingredient designed to address overactive bladder and incontinence associated with aging and childbirth, has received a large grant from the Queensland Minister for State Development and Innovation that will enable the company to further research the effectiveness of its signature ingredient, UroLogic, by undertaking more clinical trials and safety testing in the United States.
- BioLogic Health Solutions Receives Grant From Queensland Government to Conduct Further Research in U.S.
Australia-based BioLogic Health Solutions Pty Ltd., makers of UroLogic(TM), a branded dietary ingredient designed to address overactive bladder and incontinence associated with aging and childbirth, has received a large grant from the Queensland Minister for State Development and Innovation that will enable the company to further research the effectiveness of its signature ingredient, UroLogic, by undertaking more clinical trials and safety testing in the United States.
- BioLogic Health Solutions Receives Grant From Queensland Government to Conduct Further Research in U.S.
Australia-based BioLogic Health Solutions Pty Ltd., makers of UroLogic(TM), a branded dietary ingredient designed to address overactive bladder and incontinence associated with aging and childbirth, has received a large grant from the Queensland Minister for State Development and Innovation that will enable the company to further research the effectiveness of its signature ingredient, UroLogic, by undertaking more clinical trials and safety testing in the United States.
- Unigen Pharmaceuticals Presents Research Data at 46th Annual ASP Meeting
Company will present research data in an oral presentation and two posters during the 46th Annual Meeting of the American Society of Pharmacognosy (ASP) at Oregon State University July 23 – 27; oral presentation will disclose the novel mechanism of action of a proprietary ingredient called Univestin®,
- Unigen Pharmaceuticals Presents Research Data at 46th Annual ASP Meeting
Company will present research data in an oral presentation and two posters during the 46th Annual Meeting of the American Society of Pharmacognosy (ASP) at Oregon State University July 23 – 27; oral presentation will disclose the novel mechanism of action of a proprietary ingredient called Univestin®,
- Unigen Pharmaceuticals Presents Research Data at 46th Annual ASP Meeting
Company will present research data in an oral presentation and two posters during the 46th Annual Meeting of the American Society of Pharmacognosy (ASP) at Oregon State University July 23 – 27; oral presentation will disclose the novel mechanism of action of a proprietary ingredient called Univestin®,
- Unigen Pharmaceuticals Presents Research Data at 46th Annual ASP Meeting
Company will present research data in an oral presentation and two posters during the 46th Annual Meeting of the American Society of Pharmacognosy (ASP) at Oregon State University July 23 – 27; oral presentation will disclose the novel mechanism of action of a proprietary ingredient called Univestin®,
- Research Finds Flavanols in Cocoa May Help Treat Diabetes, Strokes and Dementia
Mars scientists have discovered that entire "libraries" of cocoa flavanols can be synthesized, and that new flavanols can be developed from natural flavanols.
- Research Finds Flavanols in Cocoa May Help Treat Diabetes, Strokes and Dementia
Mars scientists have discovered that entire "libraries" of cocoa flavanols can be synthesized, and that new flavanols can be developed from natural flavanols.
- Research Finds Flavanols in Cocoa May Help Treat Diabetes, Strokes and Dementia
Mars scientists have discovered that entire "libraries" of cocoa flavanols can be synthesized, and that new flavanols can be developed from natural flavanols.
- Dietary Fiber Does Help Prevent Colon Cancer, Says Harvard Men's Health Watch
New studies show that dietary fiber, previously thought to not aid against colon cancer, has a large role in preventing it, according to the August issue of the Harvard Men's Health Watch from Harvard Medical School.
- Dietary Fiber Does Help Prevent Colon Cancer, Says Harvard Men's Health Watch
New studies show that dietary fiber, previously thought to not aid against colon cancer, has a large role in preventing it, according to the August issue of the Harvard Men's Health Watch from Harvard Medical School.
- Dietary Fiber Does Help Prevent Colon Cancer, Says Harvard Men's Health Watch
New studies show that dietary fiber, previously thought to not aid against colon cancer, has a large role in preventing it, according to the August issue of the Harvard Men's Health Watch from Harvard Medical School.
- Dietary Fiber Does Help Prevent Colon Cancer, Says Harvard Men's Health Watch
New studies show that dietary fiber, previously thought to not aid against colon cancer, has a large role in preventing it, according to the August issue of the Harvard Men's Health Watch from Harvard Medical School.
- Dietary Fiber Does Help Prevent Colon Cancer, Says Harvard Men's Health Watch
New studies show that dietary fiber, previously thought to not aid against colon cancer, has a large role in preventing it, according to the August issue of the Harvard Men's Health Watch from Harvard Medical School.
- Advantra Z® Found to Contain Only P-Synephrine Isomer
Advantra Z® product was tested by independent lab confirming lack of m-synephrine; only p-synephrine isomer found.
- Advantra Z® Found to Contain Only P-Synephrine Isomer
Advantra Z® product was tested by independent lab confirming lack of m-synephrine; only p-synephrine isomer found.
- Advantra Z® Found to Contain Only P-Synephrine Isomer
Advantra Z® product was tested by independent lab confirming lack of m-synephrine; only p-synephrine isomer found.
- Advantra Z® Found to Contain Only P-Synephrine Isomer
Advantra Z® product was tested by independent lab confirming lack of m-synephrine; only p-synephrine isomer found.
- Advantra Z® Found to Contain Only P-Synephrine Isomer
Advantra Z® product was tested by independent lab confirming lack of m-synephrine; only p-synephrine isomer found.
- NEJM Publishes Study on Low-dose Echinacea for Colds
Association comments on published study; Dose found ineffective, AHPA notes concern expressed by one of the researchers that the dose may have been too low to be effective for use in colds, suggests dose or brand selection would have improved study quality.
- NEJM Publishes Study on Low-dose Echinacea for Colds
Association comments on published study; Dose found ineffective, AHPA notes concern expressed by one of the researchers that the dose may have been too low to be effective for use in colds, suggests dose or brand selection would have improved study quality.
- NEJM Publishes Study on Low-dose Echinacea for Colds
Association comments on published study; Dose found ineffective, AHPA notes concern expressed by one of the researchers that the dose may have been too low to be effective for use in colds, suggests dose or brand selection would have improved study quality.
- NEJM Publishes Study on Low-dose Echinacea for Colds
Association comments on published study; Dose found ineffective, AHPA notes concern expressed by one of the researchers that the dose may have been too low to be effective for use in colds, suggests dose or brand selection would have improved study quality.
- NEJM Publishes Study on Low-dose Echinacea for Colds
Association comments on published study; Dose found ineffective, AHPA notes concern expressed by one of the researchers that the dose may have been too low to be effective for use in colds, suggests dose or brand selection would have improved study quality.
- Herbal Science Group Says Dosage Too Low in New Echinacea Trial
Organization reviews trial results observing that it reported negative results based on preparation used against a specific virus; ABC comments on aspects of study design including extract preparation, dosing intervals and levels, and population.
- Herbal Science Group Says Dosage Too Low in New Echinacea Trial
Organization reviews trial results observing that it reported negative results based on preparation used against a specific virus; ABC comments on aspects of study design including extract preparation, dosing intervals and levels, and population.
- Herbal Science Group Says Dosage Too Low in New Echinacea Trial
Organization reviews trial results observing that it reported negative results based on preparation used against a specific virus; ABC comments on aspects of study design including extract preparation, dosing intervals and levels, and population.
- Herbal Science Group Says Dosage Too Low in New Echinacea Trial
Organization reviews trial results observing that it reported negative results based on preparation used against a specific virus; ABC comments on aspects of study design including extract preparation, dosing intervals and levels, and population.
- Research Indicates That Unique Bacopa Extract Displays Strong Serotonin Receptor Activity
Study concluded that the Bacopa extract displaces antagonist [3H]Ketanserin from serotonin receptor 5HT2a isolated from rats, and exhibited even stronger effects in its displacement of agonist 8-OH-DPAT from the 5HT1a receptor.
- Research Indicates That Unique Bacopa Extract Displays Strong Serotonin Receptor Activity
Study concluded that the Bacopa extract displaces antagonist [3H]Ketanserin from serotonin receptor 5HT2a isolated from rats, and exhibited even stronger effects in its displacement of agonist 8-OH-DPAT from the 5HT1a receptor.
- Research Indicates That Common Turmeric Fights Cancer Cells
Study published earlier this week in the journal ‘Cancer’, curcumin, the pigment that gives turmeric its yellow tint, also keeps the deadliest skin cancers from dividing and growing and in fact stimulates apoptosis—or intracellular death which causes cancer cells to kill themselves.
- Research Indicates That Common Turmeric Fights Cancer Cells
Study published earlier this week in the journal ‘Cancer’, curcumin, the pigment that gives turmeric its yellow tint, also keeps the deadliest skin cancers from dividing and growing and in fact stimulates apoptosis—or intracellular death which causes cancer cells to kill themselves.
- Research Indicates That Common Turmeric Fights Cancer Cells
Study published earlier this week in the journal ‘Cancer’, curcumin, the pigment that gives turmeric its yellow tint, also keeps the deadliest skin cancers from dividing and growing and in fact stimulates apoptosis—or intracellular death which causes cancer cells to kill themselves.
- Research Indicates That Common Turmeric Fights Cancer Cells
Study published earlier this week in the journal ‘Cancer’, curcumin, the pigment that gives turmeric its yellow tint, also keeps the deadliest skin cancers from dividing and growing and in fact stimulates apoptosis—or intracellular death which causes cancer cells to kill themselves.
- Research Indicates That Common Turmeric Fights Cancer Cells
Study published earlier this week in the journal ‘Cancer’, curcumin, the pigment that gives turmeric its yellow tint, also keeps the deadliest skin cancers from dividing and growing and in fact stimulates apoptosis—or intracellular death which causes cancer cells to kill themselves.
- FDA Satisfied with LycoRed’s GRAS Determination for Lyc-O-Mato® Powder
Safety affirmation for powder should pave way for incorporation into food products.
- FDA Satisfied with LycoRed’s GRAS Determination for Lyc-O-Mato® Powder
Safety affirmation for powder should pave way for incorporation into food products.
- FDA Satisfied with LycoRed’s GRAS Determination for Lyc-O-Mato® Powder
Safety affirmation for powder should pave way for incorporation into food products.
- FDA Satisfied with LycoRed’s GRAS Determination for Lyc-O-Mato® Powder
Safety affirmation for powder should pave way for incorporation into food products.
- FDA Satisfied with LycoRed’s GRAS Determination for Lyc-O-Mato® Powder
Safety affirmation for powder should pave way for incorporation into food products.
- Unigen Pharmaceuticals Forms Collaboration on Novel Skin Lightening Ingredient
Company announces a research and development collaboration with Professor David Minter in the Department of Chemistry at Texas Christian University (TCU) for the development of a novel skin lightening product derived from a medicinal plant.
- Unigen Pharmaceuticals Forms Collaboration on Novel Skin Lightening Ingredient
Company announces a research and development collaboration with Professor David Minter in the Department of Chemistry at Texas Christian University (TCU) for the development of a novel skin lightening product derived from a medicinal plant.
- Unigen Pharmaceuticals Forms Collaboration on Novel Skin Lightening Ingredient
Company announces a research and development collaboration with Professor David Minter in the Department of Chemistry at Texas Christian University (TCU) for the development of a novel skin lightening product derived from a medicinal plant.
- Unigen Pharmaceuticals Forms Collaboration on Novel Skin Lightening Ingredient
Company announces a research and development collaboration with Professor David Minter in the Department of Chemistry at Texas Christian University (TCU) for the development of a novel skin lightening product derived from a medicinal plant.
- Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers
placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity.
- Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers
placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity.
- Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers
placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity.
- Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers
placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity.
- Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers
placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity.
- Patients With Severe Asthma May Benefit from Increased Vitamin C Intake
Australian researchers, in a study published in The European Respiratory Journal, note that the blood concentrations of vitamin C were markedly lower in patients with severe asthma compared to subjects with mild asthma or those without asthma, and this difference was observed in both males and females.
- Patients With Severe Asthma May Benefit from Increased Vitamin C Intake
Australian researchers, in a study published in The European Respiratory Journal, note that the blood concentrations of vitamin C were markedly lower in patients with severe asthma compared to subjects with mild asthma or those without asthma, and this difference was observed in both males and females.
- Patients With Severe Asthma May Benefit from Increased Vitamin C Intake
Australian researchers, in a study published in The European Respiratory Journal, note that the blood concentrations of vitamin C were markedly lower in patients with severe asthma compared to subjects with mild asthma or those without asthma, and this difference was observed in both males and females.
- Patients With Severe Asthma May Benefit from Increased Vitamin C Intake
Australian researchers, in a study published in The European Respiratory Journal, note that the blood concentrations of vitamin C were markedly lower in patients with severe asthma compared to subjects with mild asthma or those without asthma, and this difference was observed in both males and females.
- EuroPharma® Forms Joint Venture with VitaPlant, Highly Respected Swiss Research Institute
EuroPharma’s president Terry Lemerond has entered into a joint venture with VitaPlant, the Swiss research institute for phytopharmaceutical products, to bring products researched by VitaPlant and develop partnerships with US marketing companies to introduce the products in the US.
- EuroPharma® Forms Joint Venture with VitaPlant, Highly Respected Swiss Research Institute
EuroPharma’s president Terry Lemerond has entered into a joint venture with VitaPlant, the Swiss research institute for phytopharmaceutical products, to bring products researched by VitaPlant and develop partnerships with US marketing companies to introduce the products in the US.
- EuroPharma® Forms Joint Venture with VitaPlant, Highly Respected Swiss Research Institute
EuroPharma’s president Terry Lemerond has entered into a joint venture with VitaPlant, the Swiss research institute for phytopharmaceutical products, to bring products researched by VitaPlant and develop partnerships with US marketing companies to introduce the products in the US.
- EuroPharma® Forms Joint Venture with VitaPlant, Highly Respected Swiss Research Institute
EuroPharma’s president Terry Lemerond has entered into a joint venture with VitaPlant, the Swiss research institute for phytopharmaceutical products, to bring products researched by VitaPlant and develop partnerships with US marketing companies to introduce the products in the US.
- Folates More Effective in Limiting Alzheimer's Disease Risk Than Antioxidants, Other Nutrients
Results from a long-term National Institute on Aging study of diet and brain aging indicate that the daily recommended allowance of folates reduces the risk of developing Alzheimer's disease.
- Folates More Effective in Limiting Alzheimer's Disease Risk Than Antioxidants, Other Nutrients
Results from a long-term National Institute on Aging study of diet and brain aging indicate that the daily recommended allowance of folates reduces the risk of developing Alzheimer's disease.
- Folates More Effective in Limiting Alzheimer's Disease Risk Than Antioxidants, Other Nutrients
Results from a long-term National Institute on Aging study of diet and brain aging indicate that the daily recommended allowance of folates reduces the risk of developing Alzheimer's disease.
- Folates More Effective in Limiting Alzheimer's Disease Risk Than Antioxidants, Other Nutrients
Results from a long-term National Institute on Aging study of diet and brain aging indicate that the daily recommended allowance of folates reduces the risk of developing Alzheimer's disease.
- Folates More Effective in Limiting Alzheimer's Disease Risk Than Antioxidants, Other Nutrients
Results from a long-term National Institute on Aging study of diet and brain aging indicate that the daily recommended allowance of folates reduces the risk of developing Alzheimer's disease.
- Extracts from Butterbur are an effective non-drowsy treatment for 'hay fever'
Researchers find treatment with butterbur extract was as effective at combating symptoms of intermittent allergic rhinitis as treatment with a conventional antihistamine (Telfast 180), and the Butterbur extract did not cause drowsiness.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Skepticism Arises about Conclusions of Echinacea Study
Questions are arising regarding the conclusions of a study published in this week's New England Journal of Medicine (2005, vol.353, no.4: 341-348) that reported echinacea is ineffective in preventing colds or helping treat cold-related symptoms. Specifically, industry experts are questioning why doses of echinacea that are considered far below the therapeutic threshold were used.
“Because the dosage was so much lower than what is widely used and recommended, the only real conclusion one can draw from these findings is that additional studies need to be done using doses consistent with what people normally use and find effective,” said David Seckman, executive director and CEO of NNFA.
Seckman further pointed out that even one of the study's authors, Dr. Rudolf Bauer, agreed that the study should be repeated with other echinacea species, preparations and doses, according to The New York Times article on the findings.
The dosages used in the study were equivalent to 900 milligrams of dried echinacea root per day, which is 330 percent lower than the three grams that is commonly used commercially and recommended by organizations such as the World Health Organization (WHO) and the Canadian Natural Health Products Directorate. The study examined 399 subjects infected with rhinovirus – or what is known as the common cold – who received either placebo or one of three echinacea preparations (from the species Echinacea angustifolia) prior to becoming infected and after onset of symptoms. According to the study, the echinacea groups experienced no difference from the placebo group in frequency of infections or severity and duration of symptoms.
House Passes CAFTA; Still No Threat to Supplements
On July 27, 2005, the U.S. House of Representatives passed H.R. 3045, legislation that will implement the Central America-Dominican Republic-United States Free Trade Agreement, commonly referred to as “CAFTA.” The U.S. Senate had previously passed CAFTA legislation on June 30, 2005. As NNFA has previously reported, fears that CAFTA will restrict the sale of dietary supplements in the United States are unfounded. Regardless of whether CAFTA is eventually signed into law by President Bush or what guidelines are issued at Codex, DSHEA will continue to govern the sale of dietary supplements in the United States. For more information, including statements from industry's congressional champions supporting NNFA's position, visit www.nnfa.org/codex |